![OncLive.com (@onclive) 's Twitter Profile](https://pbs.twimg.com/profile_images/1207309207004950533/hnCTQqRs_200x200.jpg)
OncLive.com
@onclive
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
ID: 43051682
http://www.onclive.com 28-05-2009 05:04:27
104,104K Tweet
45,45K Takipçi
1,1K Takip Edilen
![OncLive.com (@onclive) 's Twitter Profile Photo OncLive.com (@onclive) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1207309207004950533/hnCTQqRs_200x200.jpg)
In this episode of Oncology Unplugged, Drs 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 and Guru P. Sonpavde, MD discuss the CheckMate901 trial, which showed survival improvements with nivolumab plus chemotherapy in metastatic urothelial cancer. #oncology onclive.com/view/park-and-…
![OncLive.com (@onclive) on Twitter photo In this episode of Oncology Unplugged, Drs <a href="/CParkMD/">𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏</a> and <a href="/sonpavde/">Guru P. Sonpavde, MD</a> discuss the CheckMate901 trial, which showed survival improvements with nivolumab plus chemotherapy in metastatic urothelial cancer. #oncology onclive.com/view/park-and-… In this episode of Oncology Unplugged, Drs <a href="/CParkMD/">𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏</a> and <a href="/sonpavde/">Guru P. Sonpavde, MD</a> discuss the CheckMate901 trial, which showed survival improvements with nivolumab plus chemotherapy in metastatic urothelial cancer. #oncology onclive.com/view/park-and-…](https://pbs.twimg.com/media/GSJZUTrWIAAJobQ.jpg)